To our ASPREE participants and co-investigating GPs, The ASPREE team sincerely thanks you for supporting the ASPREE study. Without your ongoing support for medical research, this significant trial would not be possible. For the next 3 years, ASPREE will be in the ‘observational’ stage until the trial concludes at the end of 2017. This 3 year…
Details
PRESS RELEASE: Melbourne, December 1, 2014 – Australia’s largest clinical trial is a step closer to revealing in 2018 whether healthy older people should or should not take aspirin to prevent or delay cardiovascular disease (heart attack and stroke), dementia, depression and some types of cancers. ASPREE (ASPirin in Reducing Events in the Elderly), a…
Details
ASPREE Chief Investigator in Tasmania, Professor Mark Nelson gives a great interview on ABC Radio National’s Health Report about aspirin and primary prevention. He discusses the JPPP (Japanese Primary Prevention Projection) and the ASPREE trial. To listen to the interview click here. Read the transcript here.
University of Adelaide’s Professor Nigel Stocks, chief investigator to the ASPREE study in South Australia, today welcomes participants and their guests at a study update in Marion. This is the first of two scheduled events for our Adelaide participants. Invitations to the second study update, which will be held in Salisbury, will be in the post in…
Details
Bright red Proteus flowers adorned ASPREE Melbourne Manager, Dr Suzanne Orchard’s desk following her presentation to the Montrose and District Probus Club recently. So beautiful we had to tweet them, the flowers were a gift to Suzanne in appreciation for her presentation on aspirin and the ASPREE study. The pleasure is ours. We have been fortunate…
Details
PRESS RELEASE: Melbourne, 20 October 2014: The use of aspirin to prevent cancer will be discussed by experts at a symposium in Melbourne today. Leading healthcare professionals will discuss the scientific evidence for and against the use of aspirin for the chemoprevention of cancer. With the rising importance of disease prevention, researchers are looking at…
Details
Ballarat may have forgotten it was spring, but it didn’t put a dampener on meeting local ASPREE participants and guests at the study update today. We all braved the inclement weather – sun, sun, rain, downpour, FREEZING! (all in the space of a few hours) and look forward to the stories about the event on local Win News…
Details
Dr Sharyn Fitzgerald, ASPREE Regional Manager, visited her home town Wonthaggi at a study update today. Wonthaggi, a small hamlet in South Gippsland, has one of the highest participation rates in Australia, much to Sharyn’s immense pride. We would like to thank the Wonthaggi Club and the general community for their support for the ASPREE study.…
Details
Sleep apnoea refers to breathing problems that may be experienced during sleep. It is a very common disorder that is usually associated with snoring and can often be so mild that most people are not aware they have it. SNORE-ASA (SNORE-ASA: Study of Neurocognitive Outcomes, Radiological and Retinal Effects of Aspirin in Sleep Apnoea) is…
Details
Crossing the border into SA this week. With around half of ASPREE participants living in regional and rural areas, the Biobank team designed a mobile laboratory called an ASPREE ‘Biobus’. We now have two in Victoria and one in Tasmania. Each vehicle is fully equipped to collect, process and store samples over several days at a…
Details© 2019 All Rights Reserved. • Monash University, Department of Epidemiology and Preventive Medicine | Disclaimer & Privacy